Meaningful Use Measures. Reporting Time Periods Reporting Period for 1 st year of MU (Stage 1) 90 consecutive days within the calendar year Reporting.

Slides:

Advertisements

Similar presentations

Meaningful Use and Health Information Exchange

Advertisements

Dedicated to Hope, Healing and Recovery 0 Dec 2009 Interim/Proposed Rules Meaningful Use, Quality Reporting & Interoperability Standards January 10, 2010.

Meaningful Use Stage I Core Objectives

Meaningful Use Basics.  Demographics  Active Medication List  Active Allergy List  Vitals  Smoking Status  Problem List  Computerized Physician/Provider.

Understanding Meaningful Use Presented by: Allison Bryan MS, CHES December 7, 2012 Purdue Research Foundation 2012 Review of Stage 1 and Stage 2.

Eligible Hospitals (EH) & Critical Access Hospitals (CAH)

2014 Certification Criteria associated with MU Menu Stage 2: 2014 Certification Criteria associated with MU Core Stage 2: 2014 Certification Criteria associated.

Meaningful Use Performance Measures Report Carmen Land Meaningful Use National Team Business Analyst Data Networks Corporation contractor for US Indian.

Meeting Stage 1 Meaningful Use Criterion Carlos A. Leyva, Esq. Digital Business Law Group, P.A.

Meaningful Use Workgroup Improve Quality Safety, Efficiency and Reducing Health Disparities Subgroup 1 Meaningful Use Workgroup Improve Quality Safety,

TWS July2011 Stimulation Part 2. TWS July 2011 Objective: Implement drug formulary checks. Measure: The EP has enabled this functionality and has access.

TWS July 2011 Stimulation. TWS July 2011 The ARRA Stimulus Reimbursement from an ifa Customer Perspective.

Practice Management System Electronic Medical Records Accelerate Your Practice Stage 2 Meaningful Use with MVE 2014 Practice Management.

GOVERNMENT EHR FUNDING: MEANINGFUL USE STAGE 2 UPDATE October 25, 2012 Jonathan Krasner Healthcare IT Consultant BEI

Proposed Meaningful Use Criteria for Stage 2 and 3 John D. Halamka.

The Standards Rule and the NPRM for Meaningful Use John D. Halamka MD.

Series 1: Meaningful Use for Behavioral Health Providers From the CIHS Video Series “Ten Minutes at a Time” Module 2: The Role of the Certified Complete.

MEANINGFUL USE UPDATE 2014 Mark Huang, M.D. Chief Medical Information Officer Rehabilitation Institute of Chicago Associate Professor Department of PM.

WV HFMA January 23,  Understand Stage 1 changes starting in 2014  Understand Stage 2 Objectives & Quality Measures – changes from Stage 1 and.

Medicare & Medicaid EHR Incentive Programs HIT Policy Committee June 5, 2013.

Medicare & Medicaid EHR Incentive Programs

A First Look at Meaningful Use Stage 2 John D. Halamka MD.

Meaningful Use Stage 2 Esthee Van Staden September 2014.

EHRS as a Tool to Improve BP Control 1.Brief history of OQIUN, CCI. Began 1999 using data cards. Started working with multiple practice sites using different.

Series 1: Meaningful Use for Behavioral Health Providers From the CIHS Video Series “Ten Minutes at a Time” Module 2: The Role of the Certified Complete.

Practice Management System Electronic Medical Records Accelerate Your Practice Stage 1 Meaningful Use with MVE 2014 Practice Management.

New Jersey Institute of Technology Enterprise Development Center (EDC) 211 Warren Street, Newark, NJ Phone: Fax:

Meaningful Use Stage 1 & 2 Helping Colorado Providers Achieve Meaningful Use Tracy Rue Senior Consultant, Colorado Regional Extension Center.

Peter Muir MD Springfield Center for Family Medicine Collaborating Communities Health Information Exchange HealthBridge Tri-State Regional Extension Center.

NWH TRANSITION OF CARE DOCUMENT FOR MU STAGE 2 JUNE 6, 2014.

17 th Annual Scottsdale Institute Spring Conference April 14-16, 2010 Healthcare Leaders Embrace Reform Camelback Inn Scottsdale, AZ.

Christopher Geer, MBA Meaningful Use Project Manager Unity Health System

Prepared by: Health Technology Services Regional Extension Center A division of Mountain-Pacific Quality Health.

A First Look at Meaningful Use Stage 2 John D. Halamka MD.

Medicaid EHR Incentive Program For Eligible Professionals Overview of the Proposed 2015 Modification Rule Kim Davis-Allen Outreach Coordinator

Universal Adoption of the EHR What is Meaningful Use and why should it be important to me?

Affordable Healthcare IT Solutions. MU RX Compliance with Meaningful Use Stage 2.

Implementation days 10 Days Onsite Training Additional Hardware Automated Workflow Paperless Environment MD with PC Tablet / iPad Workflow Analysis.

INTRODUCTION TO THE ELECTRONIC HEALTH RECORD CHAPTER 1.

Configuring Electronic Health Records Meaningful Use and Implementation Lecture a This material (Comp11_Unit8a) was developed by Oregon Health & Science.

GloStream and Meaningful Use August, Table of Contents Final rule from the ONC and CMS The gloStream path to truly meaningful use Medicare payment.

Component 11: Configuring EHRs Unit 2: Meaningful Use of the Electronic Health Record (EHR) Lecture 1 This material was developed by Oregon Health & Science.

Unit 1b: Health Care Quality and Meaningful Use Introduction to QI and HIT This material was developed by Johns Hopkins University, funded by the Department.

1 Meaningful Use Stage 2 The Value of Performance Benchmarking.

Medicare & Medicaid EHR Incentive Programs Jason McNamara Technical Director for Health IT.

Medicare & Medicaid EHR Incentive Programs Stage 2 Final Rule Travis Broome HIT Standards Committee

Medicare & Medicaid EHR Incentive Programs Robert Anthony HIT Policy Committee March 7, 2012.

©2011 Falcon, LLC. All rights reserved. Proprietary. May not be copied or distributed without the express written permission of Falcon, LLC. Falcon EHR.

June 18, 2010 Marty Larson.  Health Information Exchange  Meaningful Use Objectives  Conclusion.

HIT Policy Committee Stage 2 Recommendations Presentation to HIT Standards Committee June 22, 2011.

Component 11/Unit 2a Meaningful Use of the Electronic Health Record (EHR)

Maine Health Information Technology (HIT)Status Report for MaineCare and Office of the State Coordinator for HIT Project Team: Andy Coburn Cathy McGuire.

Meaningful Use Made Easy Step by Step Approach to Stage 1 Compliance and 2013 Changes My Vision Express Practice Management and EMR Software Presented.

Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage.

CMS Medicare and Medicaid Electronic Health Record (EHR) Incentive Programs Final Rule Overview 1 Robert Anthony.

What Lies Ahead for ONC Meaningful Use and Beyond Farzad Mostashari, MD ScM National Coordinator for Health Information Technology.

Washington and Idaho Regional Extension Center: Job Shadow Program Peggy Evans, PhD, CPHIT WIREC Director John Hartgraves WIREC Technical Manager Bellevue.

Configuring axiUm for Meaningful Use

New Jersey Institute of Technology Enterprise Development Center (EDC) 211 Warren Street, Newark, NJ Phone: Fax:

2014 Edition Test Scenarios Development Overview Presenter: Scott Purnell-Saunders, ONC November 12, 2013 DRAFT.

Moving Toward HITECH Healthcare EHR Adoption at the Dawn of a New Era

 By phone: 1) Dial ) Enter conference ID: # Join the audio conference:  Via internet: 1) Click the phone icon 2) Click “Connect”

 By phone: 1) Dial ) Enter conference ID: # Join the audio conference:  Via internet: 1) Click the phone icon 2) Click “Connect”

Meaningful Use Update 2015: How Does It Impact Family Medicine? Ryan Mullins, MD, CPE, CPHQ, CPHIT.

Stage 2 Beyond the First Year on MU in 2014 Presenters: Randy Marsden – Chief Client Officer Leo Vilenskiy – Senior Customer Support Representative Rebecca.

Meaningful Use Objectives Overview Massachusetts Medicaid EHR Incentive Program September 16, 2016 Today’s presenters: Brendan Gallagher Thomas.

MediSYS EHR About Meaningful Use

2017 Modified Stage 2 Meaningful Use Objectives Overview Massachusetts Medicaid EHR Incentive Program September 19 & 20, 2017 September 19,

Presentation transcript:

Meaningful Use Measures

Reporting Time Periods Reporting Period for 1 st year of MU (Stage 1) 90 consecutive days within the calendar year Reporting Period for 2 nd year of MU (Stage 1) 1 calendar year (January 1-December 31) Reporting Period for 3 rd year of MU (Stage 2) Single quarter of 2014 Reporting Period for 4 th year of MU (Stage 2) 1 calendar year (January 1-December 31)

CPOE for Medication Orders Only prescriptions or medications documented by approved positions will qualify for this measure (Advanced Practitioners, Residents or Attendings) Protocol and Verbal orders will not count for this measure Proposed orders will count for this measure after they have been signed off by the provider and become active orders A patient will only qualify for this measure if there has been a medication documented on the chart (the denominator will count the patient even if there is only a documented med by history on the patient’s med list) The threshold for this measure through 2013 is >30% of patients with at least one medication order This measure will extend to >30% of lab and radiology orders in 2014 and will increase to >60% for medication orders

Maintain Up To Date Problem List This measure will qualify if at least one problem has been documented or “None” has been documented on the problem list This must show as an “Active” problem throughout the reporting period or have been Active and Resolved during that time The threshold for this measure is 80% of a provider’s patients must have at least one entry on the problem list This measure will become part of the Transitions of Care measure and will require SNOMED codes for problems in Stage 2

Maintain Active Medication List This measure will qualify as met if at least one medication has been documented in the med list or the “No Known Home Medications” box has been checked in Documented Meds by Hx The threshold for this measure is 80% of patients must have at least one entry or an indication of none recorded as structured data This measure will become part of the Transitions of Care measure in Stage 2

Maintain Active Allergy List This measure will qualify as met if at least one allergy has been documented or “No Known Allergies” has been documented The allergy must be active throughout the reporting period or have been Active and Resolved during that time. The threshold for this measure is 80% of patients must have at least one entry or an indication of none recorded as structured data This measure will become part of the Transitions of Care measure in Stage 2

Record Patient Demographics This measure will qualify as met if >50% of all patients have the appropriate demographics documented: preferred language, gender, race, ethnicity, and DOB This documentation should be recorded in IDX and pulled into Cerner via interface This measure increases to a threshold of >80% of patients in 2014

Record Vital Signs This measure will qualify as met if all vital signs have been documented on the patient: Blood Pressure, Height and Weight All Vital Signs must be present as structured data for the chosen reporting period to be considered met The threshold for this measure is >50% of patients age 2 and over This measure increases to a threshold of >80% of patients (BP ages 3 & over) in 2014

Record Smoking Status Smoking status must be entered into social history The threshold for this measure is >50% of patients age 13 and over have smoking status recorded as structured data This measure increases to a threshold of >80% of patients age 13 and over in 2014

Provide Clinical Summaries To qualify this measure as met, the depart process must be completed, printed and given to the patient You should mark that the patient has verbalized understanding and “Print & Sign” – The “Sign” alone will not qualify for this measure The threshold for this measure is >50% of all office visits within 3 business days This measure increases to a threshold of >50% of office visits within 1 business day

Perform Medication Reconciliation Medication reconciliation can be done by completing the med update in the intake form, updating the med list from within the chart or by the provider updating the med list from within their Powernote The threshold for this measure is that medication reconciliation will be completed for >50% of visits

Provide Patient Education Patient Education can be met by charting the 5 elements of education on the patient education ad hoc form, one of the the intake forms, the education form within depart or in the education section of I-View. It can also be met by pulling Exit Care instructions into the depart The threshold for this measure is >10% of patients are provided patient specific education using the EHR

Transmit Prescriptions Electronically Controlled medications will not count for or against the total prescribed counts The medication must be a prescription, meds documented by history do not count in the numerator for this measure The threshold for this measure is >40% of all permissible prescriptions at the provider level This threshold increases to >50% in 2014

Other MU Measures Implement drug-drug and drug-allergy interaction checks Implement one clinical decision support rule and ability to track compliance with the rule (increases to 5 rules in Stage 2) Report clinical quality measure to CMS Provide patients with an electronic copy of their health record within 72 hours (becomes part of view, download, transmit measure in Stage 2) Implement capability to electronically exchange key clinical information among providers and patient authorized entities (measure eliminated in Stage 2) Implement systems to protect privacy and security of patient data Implement drug formulary checks (becomes part of e-Rx measure) Incorporate clinical laboratory test results into the EHR as structured data (increases to 55% in Stage 2) Generate lists of patients by specific conditions Submit electronic immunization data to immunization registries

Other MU Measures Send patient reminders for preventive/follow-up care (Stage 2 only) Provide summary of care when patients transition to another provider (Stage 2) Implement secure messaging (Stage 2 only) Provide patients with ability to view online, download, or transmit clinical information (Stage 2 only) Submit electronic syndromic surveillance data to State (Stage 2) Record electronic progress notes (Stage 2 only) Incorporate imaging results into the EHR (Stage 2 only) Record patient family health history (Stage 2 only) Submit cancer cases to registry (Stage 2 only) Submit specific case info to specialized registries (Stage 2 only)